Investors Chronicle

On this week's show Giles Frost, chief executive officer of Amber, joins the team to explain the investment strategy of International Public Partnerships, an infrastructure investment trust. Kate Beioley, meanwhile, talks through her latest changes to the IC Top 50 ETFs, and sets out her tips for buying these kinds of funds in a cost effective way.  See acast.com/privacy for privacy and opt-out information.

IC editor John Hughman is joined by news editor Emma Powell and new recruit Julia Faurschou to discuss the week's most interesting market news, including profit wobbles at a popular bar owner and the surprising excitement over the arrival of a trendy mattress specialist on Aim.  See acast.com/privacy for privacy and opt-out information.

Since listing a year ago this week, SDX Energy has been one of Aim's top-performing stocks. For the latest in our extraction podcast series, Alex Newman talks to chief executive Paul Welch about doing business in North Africa, how the company will fund its next well, and why the company is confident of making money even if Brent crude falls to $21 a barrel. Produced by Dominic Toms.  See acast.com/privacy for privacy and opt-out information.

On this week's show Ben Yearsley, director at Shore Financial Planning, joins the team to assess the merits of some major changes Neil Woodford has made to CF Woodford Equity Income Fund. They also consider the implications of the takeover of an ETF provider, and whether it is a good idea to manage your portfolio via your smartphone.  See acast.com/privacy for privacy and opt-out information.

On this week's podcast IC editor John Hughman is joined by Ian Smith and Megan Boxall to discuss the stock market winners from last weekend's NHS cyber attack, as well as a busy week on the company reporting calendar.  See acast.com/privacy for privacy and opt-out information.

We spoke with Mike Hilton, property adviser for Phoenix Spree Deutschland (PSDL), the property group specialising in the Berlin residential market. Floated on the London Stock Exchange in June 2015, Phoenix has already accumulated a portfolio worth €400m (£336m) and is well placed to take advantage of the ever increasing demand for rental properties in Berlin.  See acast.com/privacy for privacy and opt-out information.

Ethical funds might just surprise you. They can pay higher income than you'd expect and generate healthy returns. However, they might invest in stocks you're not so keen on too... This week's Personal Finance Show takes a look at when ethical funds aren't so ethical and looks at why some of them are outperforming. The team also tackles how to beat miserly interest rates by moving away from cash and into the market and also looks at why investment trust IPOs are back in fashion. Deputy personal finance editor Kate Beioley is joined by Andrew Summers, head of fund research at Investec Wealth and Emma Agyemang, Investors Chronicle personal finance writer.  See acast.com/privacy for privacy and opt-out information.

IC editor John Hughman is joined by Ian Smith and Megan Boxall from the companies team to discuss the week's big market news, including troubles in the telco sector, turnaround potential at Pearson and a big drug trial success at AstraZeneca. Apologies for the lateness of the podcast – we had to re-record it after some technical glitches in the studio yesterday.  See acast.com/privacy for privacy and opt-out information.

Bacanora Minerals (AIM:BCN), the only pure-play lithium miner listed in London, is "100 per cent" focused on securing financing for its lithium carbonate project in Sonora, Mexico by the end of 2017. So what is it now doing on the German-Czech border? For the latest extraction podcast, natural resources writer Alex Newman visited Zinnwald in Saxony, to see Bacanora's new project with Solar World and speak to chief executive Peter Secker about Sonora, German chemicals and surging lithium demand.  See acast.com/privacy for privacy and opt-out information.

In this week's personal finance show the team look at what has been driving Artemis Global Income fund's returns, and profile some ETFs which try to eliminate the dangers of equity income. They also discuss ways to make your pension pot last through your retirement. They are joined by Rosie Bullard, portfolio manager at James Hambro & Partners.  See acast.com/privacy for privacy and opt-out information.

In this week's companies and markets podcast IC editor John Hughman chats with Megan Boxall about the companies working on cures for his rock star lifestyle, and Harriet Russell about the improving fortunes of the grocery retail industry. Produced by Alex Newman.  See acast.com/privacy for privacy and opt-out information.

Provident Financial enjoyed years of share price growth driven by its credit card subsidiary subsidiary Vanquis Bank. But its stock finished lower in 2016 as bookings fell and domestic economic concerns weighed. CEO Peter Crook talks with companies editor Ian Smith about a stronger start to 2017, and operational changes in the group's doorstep lending business. Provident's shares trade at a fairly hefty premium to their historic price-to-earnings ratio. Given the costs of growth, concerns about the UK economy and the potential disruption of its restructure - not to mention a regulatory review - should investors be nervous about its prospects?  See acast.com/privacy for privacy and opt-out information.

In this week's personal finance podcast the team highlight some of the risks facing UK equity income, and the merits of overseas equity income. They also update on Baillie Gifford Japan Trust and highlight some of the risks of taking advantage of pensions freedoms.  See acast.com/privacy for privacy and opt-out information.

Companies editor Ian Smith and guests discuss the latest ructions for energy companies alongside our review of Aim's top stocks including a look at BooHoo vs Asos and some of Aim's favourite oil stocks  See acast.com/privacy for privacy and opt-out information.

Drug pricing always comes with political noise, particularly when US elections are concerned. Over the last year, the share prices of pharmaceutical and biotech companies on both sides of the Atlantic have continually swung on the tweets and proclamations of politicians. In this special podcast, IC companies writer Megan Boxall speaks with industry insiders and tries to cut through the controversy and policy rumblings, to assess whether there are still good reasons to view pharma and biotech companies as worthwhile investments. Produced by Alex Newman and Dominic Toms, with music from Blue Dot Sessions. News clips courtesy of Fox.  See acast.com/privacy for privacy and opt-out information.

UBM started life as a newspaper company, and spent most of the last century building up its media and PR operations. But diversification is no longer the watchword. Three years ago, the company chose to concentrate on its global events business. The share price, and the special returns, show investors have benefited from that decision, but where does the investment case stand now? An acquisition-led growth model has lifted sales but also balance sheet leverage, while comparable sales have been slow in some geographies. UBM chief executive Tim Cobbold fields questions on the group's strategy from IC companies editor Ian Smith. Produced by Dominic Toms and Alex Newman.  See acast.com/privacy for privacy and opt-out information.

On this week's Personal Finance Show the team is joined by Rachel Winter, investment manager at Killik & Co. They ask whether you should go for the new three-year NS&I Investment Guaranteed Growth Bond. Its interest rate of 2.2 per cent trumps everything on the high street but it is already lagging the rate of inflation. Should you invest anyway? The team also talks inflation-beating asset allocation and high yields from frontier and emerging markets. Deputy personal finance editor Kate Beioley explores the income potential and potential hazards of frontier market investing. Finally Emma Agyemang looks at specialist trust Impax Environmental Markets' (IEM). The trust has been shooting the lights out this year but is there a Trump-shaped cloud on the horizon for this green energy flavoured trust?  See acast.com/privacy for privacy and opt-out information.

IC editor John Hughman is joined by small companies guru Simon Thompson and companies editor Ian Smith to discuss why the Aim market remains a stockpicker's paradise, and why news of snap election could spell trouble for the FTSE 100.  See acast.com/privacy for privacy and opt-out information.

Graphene and the hype surrounding atomic chicken wire Mark Robinson talks to Gareth Jones (CFO) and Jon Mabbitt (CEO) of Applied Graphene Materials about the realistic options open to investors a decade down the line after the development of the so-called wonder material.  See acast.com/privacy for privacy and opt-out information.

The North Sea, recruiters, Libor, but no mention of Brexit… Deputy companies editor Mark Robinson steps in for John Hughman in this week's look at the latest news and signals in equity markets. With news editor Emma Powell and natural resources writer Alex Newman.  See acast.com/privacy for privacy and opt-out information.